[1] Mukohda M, Okada M, Hara Y, et al.Exploring mechanisms of diabetes-related macrovascular complications:role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility[J]. J Pharmacol Sci, 2012, 118(3):303-310. [2] Berlanga J, Cibrian D, Guillen I, et al.Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds[J]. Clin Sci (Lond), 2005, 109(1):83-95. [3] Heimfarth L, Loureiro SO, Pierozan P, et al.Methylglyoxal-induced cytotoxicity in neonatal rat brain:a role for oxidative stress and MAP kinases[J]. Metab Brain Dis, 2013, 28(3):429-438. [4] McClean PL, Holscher C. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease[J]. Neuropharmacol, 2014, 76(PtA):57-67. [5] Hamilton A, Holscher C. Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system[J]. Neuroreport, 2009, 20(13):1161-1166. [6] Jin J, Kang HM, Jung J, et al.Related expressional change ofHIF-1alpha to the neuroprotective activity of exendin-4 in transient global ischemia[J]. Neuroreport, 2014, 25(1):65-70. [7] Eakin K, Li Y, Chiang YH, et al.Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats[J]. PloS One, 2013, 8(12):e82016. [8] Fukunaga M, Miyata S, Higo S, et al.Methylglyoxal induces apoptosis throughoxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells[J]. Ann N Y Acad Sci, 2005, 1043:151-157. [9] Luciani P, Deledda C, Benvenuti S, et al.Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model[J].Cell Mol Life Sci, 2010, 67(21):3711-3723. [10] Li M, Li S, Li Y, et al. Liraglutide promotes cortical neurite outgrowth via the MEK-ERK pathway[J]. Cell Mol Neurobiol, 2015, 35(7):987-993. [11] Liu WJ, Jin HY, Lee KA, et al.Neuroprotective effect ofthe glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induceddiabetic rats[J]. Br J Pharmacol, 2011, 164(5):1410-1420. [12] Qin Z, Sun Z, Huang J, et al.Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42)[J]. Neurosci Lett, 2008, 444(3):217-221. [13] McClean PL, Parthsarathy V, Faivre E, et al.The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease[J].J Neurosci, 2011, 31(17):6587-6594. [14] Wang YH, Yu HT, Pu XP, et al.Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-kappaB pathway activation in SH-SY5Y cells[J]. J Mol Neurosci, 2014, 53(4):562-570. [15] Kim J, Son JW, Lee JA, et al.Methylglyoxal induces apoptosis mediated by reactive oxygen species in bovine retinal pericytes[J]. J Korean Med Sci, 2004, 19(1):95-100. |